¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Myasthenia Gravis, Autoimmune, Experimental"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® myasthenia gravis ÇÑ±Û ÁßÁõ±ÙÀ°¹«·ÂÁõ
¼³¸í   
  È°µ¿½Ã¿¡ ±Ù´ë¾à°ú ÇǷθ¦ È£¼ÒÇÏ´Ù°¡ ¾ÈÁ¤ ÈÄ¿¡´Â È¸º¹µÇ´Â Æ¯Â¡ÀûÀΠÁõ»óÀ» È£¼ÒÇϴ º´À¸·Î, ±ÙÀ°°ú ½Å°æÁ¢ÇպΠ»çÀÌ ¿¬°áºÎºÐ ÀÌ»óÀ¸·Î ¹ß»ýÇÑ´Ù. ÁַΠÀþÀº ¿©¼º¿¡¼­ ºó¹ßÇϰí, ´«ÁÖÀ§ ±ÙÀ°À» Àߠħ¹üÇÑ´Ù. ´ë°³ ¾ÆÄ§À̳ª È޽ĠÈÄ¿¡´Â È£ÀüµÇ¾ú´Ù°¡ ¿îµ¿½Ã ¾ÇÈ­µÇ´Â ÇÇ·ÎÇö»óÀ» º¸ÀδÙ. ¸ÞÄ¿´ÏÁòÀº ¾Æ¸¶ ¸é¿ª°èÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇϴ °ÍÀ¸·Î º¸À̸ç, Ä¡·á ¶ÇÇÑ ¸é¿ªÀ» ¾ïÁ¦Çϴ ¾àÀ» ´Ù·® Åõ¿©ÇÔÀ¸·Î½á È£ÀüµÇ¾ú´Ù´Â º¸°í°¡ ¸¹´Ù. Ä§¹üºÎÀ§ÀÇ ±ÙÀ°¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, È£Èí±Ù±îÁö Ä§¹üÇϰԠµÇ¸é, È£Èí±â´É»ó½Ç·Î »ç¸ÁÇÑ´Ù. ½Å°æ-±ÙÀ° Á¢ÇպΠÁß Á¢ÇÕµÚ¸·ÀÇ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëüÀÇ Àå¾Ö°¡ ¹ß»ýÇϴ ÀÚ°¡¸é¿ªº´ÀÌ´Ù. µû¶ó¼­ ½Å°æ-±ÙÀ° Á¢Çպο¡¼­ ½Å°æÀڱؠÀü´ÞÀÌ Â÷´ÜµÇ¾î ±ÙÀ°¼è¾à°ú Á¶±â ÇǷΰ¡ ¿Â´Ù. È¯ÀÚÀÇ 85~90%¿¡¼­ Ç÷Áß¿¡ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü¿¡ ´ëÇÑ Ç×ü°¡ ÀÖ´Ù. ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂû½Ã ½Å°æ ±ÙÀ° Á¢ÇպΠÁ¢ÇÕÁÖ¸§ °¨¼Ò ¹× ´Ü¼øÈ­¸¦ º¸ÀδÙ. È¯ÀÚÀÇ 15~50%´Â °¡½¿»ùÁ¾°ú µ¿¹ÝµÇ°í ³ª¸ÓÁö´Â °¡½¿»ù°ú´ÙÇü¼º°ú Àß µ¿¹ÝµÈ´Ù. ±¤ÇÐÇö¹Ì°æ»ó¿¡¼­´Â 2Çü ±ÙÀ°¼¶À¯ÀÇ À§Ãà°ú Å»½Å°æ¿¡ ÀÇÇÑ ÀÛ°í °¢Áø ±ÙÀ°¼¶À¯°¡ ³ªÅ¸³ª´Â °Í À̿ܿ¡´Â Æ¯º°ÇÑ ¼Ò°ßÀ» º¸ÀÌÁö ¾Ê´Â´Ù.
¿µ¹® autoimmune dieases ÇÑ±Û ÀÚ°¡¸é¿ªÁúȯ
¼³¸í   
  ¸é¿ªÀ̶õ ¿Ü°è¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ÆÄ±«Çϰųª ¹«±â·ÂÈ­ ½ÃÄѼ­ ÀÚ½ÅÀ» º¸È£Çϴ ÀÏ·ÃÀÇ ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¸é¿ª¿¡¼­ °¡Àå Áß¿äÇÑ ´Ü°è´Â ÀڽŰú ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ±¸ºÐÇϴ °ÍÀÌ´Ù. ÀÚ°¡ ¸é¿ªÁúȯÀ̶õ ÀÌ·± ÀڽŰú ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀÇ ±¸ºÐÀÌ È®½ÇÇÏÁö ¸øÇÏ¿© ÀÚ½ÅÀÇ ¹°Áú·Î À߸ø ÀνÄÇÏ¿© ½º½º·Î ÀÚ½ÅÀÇ ¹°ÁúÀ» ÆÄ±«Çϴ º´À» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±Ù(À°)¹«·ÂÁõ
  • myasthenia
    ±Ù(À°)¹«·ÂÁõ
  • icterus gravis
    ÁßÁõȲ´Þ
  • icterus gravis neonatorum
    ½Å»ý¾ÆÁßÁõȲ´Þ
  • experimental epidemiology
    ½ÇÇ迪ÇÐ
  • experimental medicine
    ½ÇÇèÀÇÇÐ
  • experimental neurosis
    ½ÇÇè½Å°æÁõ
  • experimental psychology
    ½ÇÇè½É¸®ÇÐ
  • experimental psychosis
    ½ÇÇèÁ¤½Åº´
  • autoimmune
    ÀÚ°¡¸é¿ª-
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune disorder
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
  • autoimmune hepatitis
    ÀÚ°¡¸é¿ª°£¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±ÙÀ°¹«·ÂÁõ
  • experimental
    ½ÇÇè-
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • myasthenia
    ±ÙÀ°¹«·ÂÁõ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    (¢¡gravis) ÁßÁõ±ÙÀ°¹«·ÂÁõ
  • myasthenia
    ±ÙÀ°¹«·ÂÁõ
  • myasthenia ocularis
    ´«±ÙÀ°¹«·ÂÁõ
  • icterus gravis
    ÁßÁõȲ´Þ
  • icterus gravis neonatorum
    ½Å»ý¾ÆÁßÁõȲ´Þ
  • mania gravis
    ÁßÁ¶º´
  • melancholia gravis
    ÁßÁõ¿ì¿ïº´
  • experimental
    ½ÇÇè-
  • experimental epidemiology
    ½ÇÇ迪ÇÐ
  • experimental medicine
    ½ÇÇèÀÇÇÐ
  • experimental neurosis
    ½ÇÇè½Å°æÁõ
  • experimental psychology
    ½ÇÇè½É¸®ÇÐ
  • experimental psychosis
    ½ÇÇèÁ¤½Åº´
  • autoimmune
    ÀÚ°¡¸é¿ª-
  • autoimmune disease
    ÀÚ°¡¸é¿ªº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MG=£¾myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ.
  • MG=£¾myasthenia gravis
    ÁßÁõ ±Ù¹«·ÂÁõ.
  • icterus gravis
    ÁßÁõȲ´Þ(ñìñø)
  • icterus gravis neonatorum ³ª
    ½Å»ý¾ÆÁßÁõ (¼º) Ȳ´Þ(ãæßæä®ñìñøàõüÜÓ¸).
  • icterus gravis ³ª
    ÁßÁõ(¼º) Ȳ´Þ(ñìñøàõüÜ Ó¸).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ(ñìñø) ±Ù¹«·ÂÁõ
  • myasthenia gravis juvenilis ³ª
    ¿¬¼Ò¼º ÁßÁõ ±Ù¹«·ÂÁõ.
  • myasthenia gravis pseudoparalytica ³ª
    °¡¼º¸¶ºñ¼º ÁßÁõ±Ù¹«·ÂÁõ.
  • myasthenia gravis syndrome ³ª
    ÁßÁõ±Ù¹«·ÂÁõÈıº(ýªÔéÐÉÙëæ³ñø).
  • experimental hydremic plethora
    ½ÇÇèÀû ¼öÇ÷°ú´ÙÁõ(ãùúÐîÜâ©úìΦÒý
  • experimental medicine
    ½ÇÇèÀÇÇÐ(ãùúÐì¢ùÊ).
  • experimental medicine
    ½ÇÇèÀÇÇÐ(¡­ì¢ùÊ).
  • experimental neurosis See neurosis
    ½ÇÇè½Å°æÁõ(ãùúÐãêÌèñø)
  • experimental pharmacology
    ½ÇÇè¾à¸®ÇÐ(¡­å·ìµùÊ).
  • experimental physiology
    ½ÇÇè»ý¸®ÇÐ(¡­ßæìµùÊ).
  • experimental psychology See psychology
    ½ÇÇè½É¸®ÇÐ(ãùúÐãý×âùÊ)
  • experimental psychosis See psychosis
    ½ÇÇèÁ¤½ÅÁõ(º´)(ãùúÐïñãêñø)
  • asthenia gravis hypophyseogenea<³ª>
    ³úÇϼöü¼º ÁßÁõ¹«·Â(Áõ).
  • epilepsia gravis et mitis<³ª>
    Áß°æÁõ(ñìÌîñø)°£Áú.
  • icterus gravis
    ÁßÁõȲ´Þ(ñìñø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune complement fixation
    ÀÚ°¡¸é¿ª (í»Ê«Øóæ¹) º¸Ã¼°íÁ¤ (ÜÍô÷ͳïÒ)
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ (í»Ê«Øóæ¹òðü´)
  • autoimmune response
    ÀÚ°¡¸é¿ª´ëÀÀ (í»Ê«Øóæ¹Óßëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ
  • autoimmune
    ÀÚ°¡¸é¿ª
  • experimental animal
    ½ÇÇ赿¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EAMG experimental autoimmune myasthenia gravis
EAT Eating Attitudes Test; Ehrlich ascites tumor; electro-aerosol therapy; epidermolysis acuta toxica; e...
JAMG juvenile autoimmune myasthenia gravis
EAE experimental allergic encephalomyelitis; experimental autoimmune encephalitis
MG   1) Myasthenia Gravis
  2) MonoGlyceride
  3) Monoclonal Gammop...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EAMG Experimental Autoimmune Myasthenia Gravis
MG MYASTHENIA GRAVIS
CR-EAE Chronic relapsing experimental autoimmune encephalomyelitis
EAE Experimental Autoimmune Encephalomyelitis
EAP Experimental Autoimmune Pinealitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • icterus gravis
    ÁßÁõ Ȳ´Þ, ÁßÁõ¼º Ȳ´Þ
  • myasthenia gastrics
    À§ ±Ù ¹«·ÂÁõ
  • myasthenia ocularis
    ¾È±Ù ¹«·ÂÁõ
  • experimental allergic encephalomyelitis
    ½ÇÇèÀû ¾Ë·¹¸£±â¼º ³ú ô¼ö¿°
    ³ú ¶Ç´Â ô¼ö¸¦ ¿ÏÀü adjuvant¿Í ÇÔ²² ÁÖ»ç, ¸é¿ª½ÃÄÑ ½ÇÇèÀûÀ¸·Î ¸¸µç ¾Ë·¹¸£±â¼º ³ú ô¼ö¿°. Guinea
  • experimental allergic neuritis
    ½ÇÇèÀû ¾Ë·¹¸£±â¼º ½Å°æ¿°
    ÀÌ ÁúȯÀº Freund ¿ÏÀü adjuvant¸¦ À¯Á¦·Î ÇÑ µ¿Á¾ ¶Ç´Â ÀÌÁ¾ µ¿¹° À¯·¡ÀÇ ¸»ÃÊ ½Å°æ ÃßÃâ¹° ȤÀº ¸»ÃÊ ½Å°æ ´Ü¹éÁúÀ» ½ÇÇè µ¿¹°¿¡ Åõ¿©Çϸé 10-24ÀÏ ÈÄ¿¡ ¹«·Â, ¸¶ºñÀÇ Áõ»óÀ» ÀÏÀ¸Å°´Â ÀÏÁ¾ÀÇ ÀÚ°¡ ¸é¿ª¼º ½Å°æ¿°ÀÌ´Ù. ÁÖµÈ ¿øÀÎÀº ¼¼Æ÷¼º ¸é¿ª ±âÀü¿¡ ÀÇÇÑ °ÍÀ¸·Î µÇ¾î ÀÖ´Ù.
  • experimental allergic thyroiditis
    ½ÇÇèÀû ¾Ë·¹¸£±â¼º °©»ó¼±¿°
    ¹«¾ùÀΰ¡ÀÇ ¸é¿ªÇÐÀû 󸮿¡ ÀÇÇÏ¿© µ¿¹°¿¡ ½ÇÇèÀûÀ¸·Î ¾ß±âµÈ °©»ó¼±ÀÇ ÃÑĪ. »ç¶÷ÀÇ ¸¸¼º °©»ó¼±¿°°ú À¯»çÇϱ⠶§¹®¿¡ ±× ¸ðµ¨·Î µÇ¾î ÀÖ´Ù, ÀÚ±â thyroglobulin¿¡ ´ëÇÑ T ¼¼Æ÷´Â ¿ªÄ¡ÀÇ »óÅ¿¡ ÀÖÁö¸¸ B
  • experimental animal
    ½ÇÇè µ¿¹°
    ½ÇÇè½Ç¿¡¼­ ½ÇÇè ¿¬±¸ÀÇ Àç·á·Î¼­ »çÀ°ÇÏ´Â µ¿¹°.
  • experimental medicine
    ½ÇÇè ÀÇÇÐ
  • experimental pharmacology
    ½ÇÇè ¾à¸®ÇÐ
  • autoimmune
    ÀÚ°¡ ¸é¿ª
    ÀÚ°¡ ¸é¿ª¿¡ °üÇÑ.
  • autoimmune blood dyscrasia
    ÀÚ°¡ ¸é¿ª¼º Ç÷¾× ÀÌ»ó
  • autoimmune disorder
    ÀÚ°¡ ¸é¿ª Àå¾Ö
    ½Åü°¡ ÀÚ±â Àڽſ¡ ´ëÇØ Àå¾Ö°¡ ÀÖ´Â ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸ÄÑ ·ù¸¶Æ¼¼º °üÀý¿°, ÇǺΠ°æÈ­Áõ°ú °°ÀÌ ÀÚ½ÅÀÇ Á¶Á÷ ÆÄ±«¸¦ À¯¹ßÇÏ´Â Áúȯ.
  • autoimmune hemolytic disease
    ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º Áúȯ
  • autoimmune progesterone dermatitis
    ÀÚ°¡ ¸é¿ª ÇÁ·Î°Ô½ºÅ×·Ð ÇǺο°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
myasthenia gravis <disease, neurology> The characteristic feature of the disease is easy fatigue of certain voluntary muscle groups on repeated use. Muscles of the face or upper trunk are especially likely to be affected. In most and perhaps all cases due to the development of autoantibodies against the acetylcholine receptor in neuromuscular junctions. Immunisation of mice or rats with this receptor protein leads to a disease with the features of myasthenia.
(18 Nov 1997)
myasthenia gravis and thymoma <radiology> Of patients with MG 15% have thymoma, of patients with thymoma 50% have MG
(12 Dec 1998)
myasthenia <anatomy, neurology> Muscular debility, any constitutional anomaly of muscle.
Origin: Gr. Astheneia = weakness
(18 Nov 1997)
myasthenia angiosclerotica <symptom> A symptom complex characterised by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest.
(12 Dec 1998)
anaemia gravis <haematology> This form of anaemia occurs when the bone marrow ceases sufficient red and white blood cell production. It may be induced by exposures to high levels of toxic chemicals, radiation and certain drugs.
It is generally unresponsive to specific therapy, often accompanied by granulocytopenia and thrombocytopenia, in which the bone marrow may not necessarily be hypocellular or hypoplastic but fails to produce adequate numbers of peripheral blood elements. The term actually is all inclusive and most probably encompasses several clinical syndromes.
Origin: Gr. Haima = blood
(29 Sep 1997)
colitis gravis An obsolete term for ulcerative colitis.
(05 Mar 2000)
neurasthenia gravis A condition of extreme and lasting neurasthenia.
(05 Mar 2000)
icterus gravis Jaundice associated with high fever and delirium; seen in severe hepatitis and other diseases of the liver with severe functional failure.
Synonym: malignant jaundice.
(05 Mar 2000)
oneirodynia gravis 1. A fiend or incubus formerly supposed to cause trouble in sleep.
2. A condition in sleep usually caused by improper eating or by digestive or nervous troubles, and characterised by a sense of extreme uneasiness or discomfort (as of weight on the chest or stomach, impossibility of motion or speech, etc), or by frightful or oppressive dreams, from which one wakes after extreme anxiety, in a troubled state of mind; incubus.
3. Hence, any overwhelming, oppressive, or stupefying influence.
Origin: Night + mare incubus. See Mare incubus.
Source: Websters Dictionary
(01 Mar 1998)
anaemia, haemolytic, autoimmune Acquired haemolytic anaemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red cells.
(12 Dec 1998)
autoimmune <immunology> Pertaining to autoimmunity.
(02 Jan 1998)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
autoimmune diseases Are illnesses which occur when the body tissues are attacked by its own immune system. The immune system is a complex organisation within the body that is designed normally to seek and destroy invaders of the body, particularly infections. Patients with these diseases have unusual antibodies in their blood that target their own body tissues.
(12 Dec 1998)
autoimmune haemolytic anaemia <haematology> A condition that results from the cellular destruction (haemolysis) of red blood cells due to antibodies formed to components on the surface of the red blood cells.
Origin: Gr. Haima = blood
(02 Jan 1998)
autoimmune hepatitis <pathology> A type of chronic active hepatitis that results from circulating auto-antibodies and chronic inflammation of the liver.
Symptoms are those of chronic active hepatitis.
(27 Sep 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Myasthenia Gravis, Autoimmune, Experimental - »õâ Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)
    Synonyms : Autoimmune Experimental Myasthenia Gravis, Experimental Autoimmune Myasthenia Gravis, Passive Transfer, Experimental Myasthenia, Experimental Myasthenia Gravis, Myasthenia Gravis, Autoimmune Experimental, Experimental Myasthenias, Myasthenia, Experimental
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune
    ÀÚ±â(ÀÚ°¡)¸é¿ªÀÇ
  • experimental
    ½ÇÇè¿¡ ÀÇÇÑ;½ÇÇèÀûÀÎ;½ÇÇè¿ëÀÇ;°æÇè¿¡ ÀÇÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á